Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
IART
JANX
Add up to 3 more stocks
IART
Integra LifeSciences Holdings Corporation
+0.23%
$13.32+0.03Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.04B
52W Range
$8.70 - $20.49
JANX
Janux Therapeutics, Inc.
+1.51%
$16.79+0.25Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.02B
52W Range
$12.12 - $35.34
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | 5.46 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.99 | 1.10 |
| P/S Ratio | 0.63 | 32.12 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | 3.54 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 53.7% | 79.7% |
| Operating Margin | 4.2% | -1576.7% |
| Net Margin | -0.4% | -321.8% |
| ROE | -0.7% | -11.1% |
| ROA | -0.2% | -10.2% |
| ROIC | 20.0% | -15.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.40 | 16.35 |
| Quick Ratio | 1.98 | 16.35 |
| Debt/Equity | 1.94 | 0.02 |
| Interest Coverage | 0.79 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.